









Markets
/
Stocks
/
nasdaq-bbot
/

BridgeBio Oncology Therapeutics Ord Shs

BBOT

12.180USD

-0.340-2.72%

Close 12/22, 16:00（ET）Quotes delayed by 15 min

286.34MMarket Cap

60.33P/E TTM



BridgeBio Oncology Therapeutics Ord Shs

12.180

-0.340-2.72%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of BridgeBio Oncology Therapeutics Ord Shs here for insights into the performance and operational efficiency of BridgeBio Oncology Therapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Operating expenses

--1.16M

Operating profit

---1.16M

Net non-operating interest income (expenses)

Non-operating interest income

--2.08M

Income before tax

--918.31K

Income after tax

--918.31K

Net income from continuous operations

--918.31K

Net income attributable to controlling interests

--918.31K

Net income attributable to common shareholders

--918.31K

Basic earnings per share

--0.04

Diluted earnings per share

--0.04

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

